Novartis Wins U.S. Approval for First of New Psoriasis Drugs – Bloomberg
Novartis Wins U.S. Approval for First of New Psoriasis DrugsBloombergOlder treatments such as Enbrel and Humira block a protein called TNF that signals the body to create inflammation. Stelara targets proteins known as IL-12 and IL-23, while secukinumab goes after IL-17A, which only recently has been linked to psoriasis.
Novartis Makes Headway into Health Technology; Collaborates with Rani to … – NYC Today
The Star OnlineNovartis Makes Headway into Health Technology; Collaborates with Rani to …NYC TodayNovartis is optimistic that this early-stage technology can be incredibly used with insulin and as well as with a wide range of other injected medicines including treatments for rheumatoid arthritis, psoriasis and multiple sclerosis. Rani informed that …Novartis digs into health tech with bet on 'robotic pill'WHBL Sheboyganall 53 news articles »